| Review of Particle Physics | Progress of Theoretical and Experimental Physics | 2020 | 1.1K |
| Overall Survival with Osimertinib in Untreated, -Mutated Advanced NSCLC | New England Journal of Medicine | 2020 | 771 |
| A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement | Journal of Hepatology | 2020 | 764 |
| Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study | Lancet Oncology, The | 2020 | 500 |
| TRY plant trait database - enhanced coverage and open access | Global Change Biology | 2020 | 399 |
| Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19 | Science Immunology | 2020 | 369 |
| Synthetic ratiometric fluorescent probes for detection of ions | Chemical Society Reviews | 2020 | 310 |
| Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers | Cell | 2020 | 288 |
| Impact of coronavirus syndromes on physical and mental health of health care workers: Systematic review and meta-analysis | Journal of Affective Disorders | 2020 | 251 |
| Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea | Journal of Korean Medical Science | 2020 | 222 |
| Durvalumab With or Without Tremelimumab vs Standard Chemotherapy in First-line Treatment of Metastatic Non-Small Cell Lung Cancer: The MYSTIC Phase 3 Randomized Clinical Trial | JAMA Oncology | 2020 | 205 |
| Three-Year Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC-Update from PACIFIC | Journal of Thoracic Oncology | 2020 | 203 |
| Guidelines for Laboratory Diagnosis of Coronavirus Disease 2019 (COVID-19) in Korea | Annals of Laboratory Medicine | 2020 | 199 |
| Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial | JAMA Oncology | 2020 | 196 |
| Blockchained On-Device Federated Learning | IEEE Communications Letters | 2020 | 191 |
| Reconfigurable Intelligent Surface-Based Wireless Communications: Antenna Design, Prototyping, and Experimental Results | IEEE Access | 2020 | 190 |
| Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial | Lancet, The | 2020 | 189 |
| Proton Transport in Metal-Organic Frameworks | Chemical Reviews | 2020 | 173 |
| Fighting COVID-19 with Agility, Transparency, and Participation: Wicked Policy Problems and New Governance Challenges | Public Administration Review | 2020 | 173 |
| Asymptomatic patients as a source of COVID-19 infections: A systematic review and meta-analysis | International Journal of Infectious Diseases | 2020 | 170 |
| Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III KEYNOTE-604 Study | Journal of Clinical Oncology | 2020 | 160 |
| Performance-limiting nanoscale trap clusters at grain junctions in halide perovskites | Nature | 2020 | 155 |
| Effect of Ticagrelor Monotherapy vs Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events in Patients With Acute Coronary Syndrome: The TICO Randomized Clinical Trial | JAMA - Journal of the American Medical Association | 2020 | 151 |
| COVID-19: A global transplant perspective on successfully navigating a pandemic | American Journal of Transplantation | 2020 | 149 |
| A Review of Low-Temperature Solution-Processed Metal Oxide Thin-Film Transistors for Flexible Electronics | Advanced Functional Materials | 2020 | 133 |
